Scientific Advisors

Scientific Advisors

Michael Karin, PhD

Michael Karin, PhD

Professor of Pharmacology
Ben and Wanda Hildyard Chair
Mitochondrial and Metabolic Diseases
University of California, San Diego
Expert in mitochondria, inflammation, and metabolic diseases.

Steven Kahn, MD

Steven Kahn, MD

Professor of Medicine and Metabolism
University of Washington
Clinical leadership positions in numerous T2D trials including the Diabetes Prevention Program, Diabetes Prevention Program Outcomes Study (DDP / DPPOS), Look AHEAD, Restoring Insulin Secretion Study (RISE) and Glycemia Reduction Approaches in Diabetes (GRADE).

Kent Bodensgaard, PhD

Kent Bodensgaard, PhD

Senior Vice President
Antibody Discovery, Alloy Therapeutics (US)
Former Director, Antibody Technology, Novo Nordisk (DK)